Supreme Court to hear arguments on generic drug liability

This month, Supreme Court justices will hear arguments in the case of a Maine woman suing a generic-drug maker over claims of damage from a generic nonsteroidal anti-inflammatory drug. The maker of the treatment says it cannot be held liable because it was not responsible for the design of the drug.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs: